Biotechnology

India is among the top 12 global destinations and 3rd in the Asia-Pacific region in Biotechnology R&D.

Last updated: June 1, 2021

Out of India's top 10 biotech companies, seven are in bio-pharmaceuticals and three in agri-biotech.

100%

FDI through automatic route for new projects.

No.1

producer of recombinant Hepatitis B vaccine.

2nd

highest number of USFDA-approved plants outside the US.

No.1

producer of BT cotton variety in the world.

US$150bn

projected value of biotech sector by 2025 with 30.5% CAGR.

Leading

destination for clinical trials, contract research, and manufacturing.

+500

USFDA approved pharma plants in India; 2nd largest outside of USA.

800

biotechnology companies in India, driving global partnerships.

55+

bio-incubators and 9 biotech parks, with new ones in the pipeline.

Bioenergy Road Map 2020

To achieve 20% blending of fossil fuel by 2020, among other targets.
National Biotechnology Development Strategy

To establish India as a world class bio-manufacturing hub.

Open Access Policy Of DBT And DST, Govt. of India

To support basic, transitional and applied scientific research.

Biotechnology Ignition Grant

The scheme enables technology innovators and entrepreneurs to pursue a promising technology idea, and establish and validate proof of concept (POC) for the idea.
Guidelines on Similar Biologics

The “Guidelines on Similar Biologics” prepared by Central Drugs Standard Control Organization (CDSCO) and the Department of Biotechnology (DBT) lay down the regulatory pathway for a Similar Biologic claiming to be Similar to an already authorized Reference Biologic.
National Biotechnology Parks Scheme

The Biotechnology Parks, offer facilities to Scientists, and Small and Medium sized Enterprises (SMEs) for technology incubation, technology demonstration and pilot plant studies for accelerated commercial development of innovative leads.
National Guidelines for Stem Cell Research

In recent years, stem cell research has emerged as an important area of biomedical science.
COVID-19 Research for Diagnostics, Vaccines and Therapeutics

A Research strategy has been evolved at the Department of Biotechnology (DBT) for immediate response and long-term preparedness to combat COVID-19 infection.

S&T Efforts in India on COVID-19

Vigyan Prasar (VP) has been covering the pandemic since the early days with the science communication perspective and journalistic flavour, ensuring that science and safety are the primary focus. VP is a national level organization of the Department of Science and Technology, Government of India, engaged in science communication and popularization.
The DNA Technology (Use and Application) Regulation Bill - 2019

Recognizing the need for regulation of the use and application of Deoxyribonucleic Acid (DNA) technology in the country, “The DNA Technology (Use and Application) Regulation Bill - 2019”, has been formulated for establishing identity of missing persons, victims, offenders, under trials and unknown deceased persons.
Guidelines for Evaluation of Probiotics in Food

The Department of Biotechnology formulates guidelines to help conduct research in the different areas of biosciences and promote its use in the industry and utility among the people.

National Biopharma Mission

The Mission is part of an Industry-Academia collaboration that aims to make India the hub for the designing and manufacturing of biotechnological commodities.

Scheme for Facilitating Start-Ups Intellectual Property Protection (SIPP)

The scheme of SIPP aims to promote awareness and adoption of Intellectual Property Rights amongst Startups.

Department of Science & Technology

dstsec@nic.in

+91-11-26567373, 26962819

Visit Website

The department plays a pivotal role in promotion of science & technology in the country

Biotechnology Industry Research Assistance Council

birac.dbt@nic.in

+ 91-11-24389600

Visit Website

A public sector undertaking of the Department of Biotechnology.

Council of Scientific & Industrial Research

sk@csir.res.in

011-23710618

Visit Website

CSIR, known for its cutting edge R&D knowledge base in diverse S&T areas, is a contemporary R&D organization.

Autonomous S&T Institutions

anju_bhalla@nic.in

+91-11-26562122/25/33/44,

Visit Website

A comprehensive list of S&T research organisations around India.

Department of Biotechnology

+91-11-26511439, 26510068, 23386051

Visit Website

Department of Biotechnology (DBT) was set up in 1986, within the Ministry of Science and Technology, making India one of the first countries to have a separate department for this stream of science and technology.

Department of Biotechnology

investment opportunities

  • Clinical studies and drug research
  • Development of medical devices
  • R&D activity around Biosimilars
  • Secondary agriculture research
  • Biotech parks and infrastructure
Useful Links:

key investors

India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive and capital establishments

Abbot Laboratories - American health care company

Sanofi Aventis - providers of diabetes drugs and vaccines

Endo Pharmaceuticals - Generics and speciality manufacturer

GE Healthcare - Medical equipment & diagnostic products

Bosch - Healthcare and medical technology manufacturer

Helix - Planning and design of healthcare facilities

BPI - IT solutions for business requirements in life sciences

Tekes - Financing research, development and innovation

ENABLING ENVIRONMENT

India has a well-oiled enterprise promoting machinery that is backed by strong legislative, judiciary, executive, and capital establishments

AWS to participate in digital adoption among companies Read More
US and India Collaboration to Fight the COVID-19 and Climate Change Read More
India-Japan-Australia Supply Chain looks to include ASEAN nations Read More
India FDI Boost Through Conducive Government Policies Read More
PLI for the chemical sector under consultation Read More
Commitment to green energy investment remains sustained despite the pandemic Read More

News

Bolstering policies for a vibrant Bioeconomy

August 17, 2021

Union Budget 2021-22

February 2, 2021

Govt stimulus package of US$122mn to aid vaccine development

December 1, 2020

Multilateral supply chains to be made more resilient in the face of COVID-19 impact

November 27, 2020

India’s policies: Boosting growth

June 5, 2020
View All

Events

Oct 28,2021

Asia Health 2021
View More